Abstract
A selective and sensitive liquid chromatography–mass spectrometric method in ESI (+ve) mode was developed and validated completely in human plasma. Clonidine and IS, carbamazapine, were extracted from human plasma via liquid–liquid extraction with ethyl acetate. Following evaporation under nitrogen, the residue was reconstituted with mobile phase and analyzed using API 4000 LC–MS–MS system. An isocratic program with binary mobile phases (0.1% formic acid in water and acetonitrile) was used to separate interference peaks by a C18 analytical column. Linearity range was 0.49–73.98 ng mL−1. The intra- and inter-day accuracy and precision were within acceptable limits (≤15%). This method was successfully applied to a single dose 25 μg tablets BE study of clonidine in healthy male volunteers.
Similar content being viewed by others
References
National Institute of Neurological Disorders and Stroke (2002) http://www.ninds.nih.gov/news_and_events/news_articles/news_article_adhd.htm
Schapiro NA (2002) Dude, you don’t have Tourette’s: Tourette’s syndrome, beyond the tics. Pediatr Nurs. 28: 243–246, 249–253. PMID 12087644
Howard S (2008) Illustrated pharmacology memory cards: pharmnemonics. Minireview, 12. ISBN 1-59541-101-1
Gourlay SG, Stead LF, Benowitz NL (2004) Clonidine for smoking cessation. Cochrane Database Syst Rev 2004, (2) Art. No.: CD000058. doi:10.1002/14651858.CD000058.pub2
Müller C, Ramic M, Harlfinger S, Hünseler C, Theisohn M, Roth B (2007) J Chromatogr A 1139(2). doi:10.1016/j.chroma.2006.11.020
Gergov M, Ojanperä I, Vuori E (2003) J Chromatogr B 795(1). doi:10.1016/S1570-0232(03)00498-7
Pelzer M, Addison T, Li W, Jiang X, Weng N (2002) J Liq Chromatogr Relat Technol 25(7). doi:10.1081/JLC-120003421
Parekh SA, Pudage A, Joshi SS, Vaidya VV, Gomes NA (2008) J Chromatogr B 867 (2). doi:10.1016/j.jchromb.2008.03.030
Ke GM, Wang L, Xue HY, Lu WL, Zhang X, Zhang Q, Guo HY (2005) Biol Pharm Bull 28
Wenzl T, Lankmayr EP, Wintersteiger R, Sadjak A, Likar R, Zakel D (2002) J Biochem Biophys Methods 53(1–3). doi:10.1016/S0165-022X(02)00101-X
Guidance for Industry, Bioanalytical Method Validation (2001) Food and Drug Administration, Center for Drug Evaluation and Research (CDER)
Shah VP, Midha KK, Findlay JWA, Hill HM, Hulse JD, McGilvery IJ, McKay G, Miller KJ, Patnaik RN, Powel ML, Tonelli A, Viswanathan CT, Yacobi A (2000) Pharm Res 17:1551. doi:10.1023/A:1007669411738
McDoall RD, Hartman C, Penninkx W, Hayden YV, Pankeerberghen V, Massart DL (1995) In: Blume HH, Midha KK bio’94, bio-international 2, bioavailability, bioequivalence and pharmacokinetic studies, Medpharm Scientific, Stuttguart, Germany, p 331
Nagaraja NV, Paliwal JK, Gupta RC (1999) J Pharm Biomed Anal 20:433. doi:10.1016/S0731-7085(98)00256-8
Almeida AM, CastelBranco MM, Falcao AC (2002) J Chromatogr B 774:215. doi:10.1016/S1570-0232(02)00244-1
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ghosh, C., Singh, R.P., Inamdar, S. et al. Sensitive, Selective, Precise and Accurate LC–MS Method for Determination of Clonidine in Human Plasma. Chroma 69, 1227–1232 (2009). https://doi.org/10.1365/s10337-009-1102-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-009-1102-3